Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.67 |
| ▸ | CNR1 | P21554 | 8/20 | 0.67 |
| ▸ | TRPV1 | Q8NER1 | 5/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.53 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.53 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.53 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 0.53 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22048690 | 1.00 | CNR2 (0.67) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL26258469 | 0.97 | CNR2 (0.62) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL26706569 | 0.93 | CNR2 (0.58) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL11737119 | 0.85 | CNR2 (0.71) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL31544847 | 0.85 | CNR2 (0.71) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL11816067 | 0.85 | CNR2 (0.71) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL11739308 | 0.84 | CNR2 (0.72) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL11737623 | 0.84 | CNR2 (0.72) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL11336905 | 0.82 | CNR2 (0.67) | CNR2CNR1TRPV1OPRM1TRPA1 | |
| SCHEMBL24538119 | 0.82 | CNR2 (0.64) | CNR2CNR1TRPV1OPRM1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340446-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230340446-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2023-10-26 | — | — | US | disclosed |
| US-20220387352-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | MEDTERRA PHARMA LLC | 2022-12-08 | — | — | US | disclosed |
| WO-2011110866-A1 | PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER | GW PHARMA LIMITED (GB) | 2011-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387352-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USING FOR THE TREATMENT OF NON-EOSINOPHILIC INFLAMMATION AND INFLAMMATORY DISORDERS | CNR2, CNR1, FAAH2 | CNR2 1/4885CNR1 2/4885TRPV1 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.